HIV-1-Gag Conserved-Element DNA Vaccine (p24CE) Vaccine Study

NCT03560258 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

45

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: p24CE1/2 pDNA vaccine
BIOLOGICAL: p24CE1/2 pDNA vaccine admixed with full-length p55^gag pDNA vaccine
BIOLOGICAL: Full-length p55^gag pDNA vaccine
BIOLOGICAL: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)